Newsroom

ReCheck enters the market at a critical inflection point. Healthcare organizations are facing mounting complexity in building resilient supply chains while simultaneously confronting a once-in-a-generation opportunity to leverage artificial intelligence to transform operations. With more than 4,000 FDA device recalls issued annually—and 70% of hospitals still relying on manual processes—the gap between recall notification and action has never been more consequential.

“Every recalled device that goes undetected in a hospital is a risk to someone’s life,” said a ReCheck spokesperson. “ReCheck exists to close the gap between an FDA recall announcement and the moment a clinician stops using that device.”

Hospitals today manage between 5,000 and 10,000 unique medical devices across departments, warehouses, and surgical trays. When a recall occurs, the challenge is not simply whether the product is in the supply chain—but how quickly it can be identified and removed. Traditional, manual cross-referencing processes are slow, error-prone, and often too late to prevent exposure.

ReCheck addresses this challenge with an AI-native infrastructure platform purpose-built to dismantle entrenched legacy workflows and make sense of the disparate data critical for recall management. At its core is an intelligent orchestration layer that sits between FDA recall data and healthcare providers, managing the full lifecycle of recall response.

The platform enables organizations to:

• Immediately receive relevant recall alerts enriched with actionable insights
• Automatically determine whether recalled products exist within their supply chain
• Execute structured workflows to track response actions and ensure compliance
• Prepare seamlessly for regulatory and Joint Commission audits
• Continuously monitor for newly recalled products that may impact inventory

Powered by an “ask anything” AI Assistant and a mobile-first Smart App, ReCheck ensures that supply chain and clinical teams can respond in real time—when it matters most.

“Legacy processes inject risk into the supply chain,” the spokesperson added. “ReCheck replaces that risk with intelligence—delivering immediate visibility, automated analysis, and ongoing management of supply chain exposure.”

With more than 68,000 FDA recalls indexed and continuously analyzed, ReCheck provides immediate supply chain insight and persistent risk monitoring. Its AI-driven capabilities enable healthcare organizations to shift from reactive recall handling to proactive risk management—fundamentally strengthening supply chain resiliency.

As healthcare systems continue to navigate increasing operational complexity, ReCheck represents a critical step forward in aligning patient safety with modern, AI-powered infrastructure.

About ReCheck
ReCheck is an AI-native infrastructure platform headquartered in Nashville, Tennessee, focused on transforming healthcare recall management. By bridging the gap between regulatory data and provider operations, ReCheck empowers healthcare organizations to protect patients, reduce risk, and build more resilient supply chains.